FDA Inspection 1154304 — Peter Charles Klatsky MD Inc
The FDA completed an inspection of Peter Charles Klatsky MD Inc on Oct 7, 2021 in New York, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 7, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- New York, NY (United States)